Cystic fibrosis: management and monitoring of respiratory manifestations An overview of the pharmacological management of respiratory symptoms in people with cystic fibrosis to ensure they can optimise benefit from their medication regime.
Copy link to page Download PDF
Shutterstock.com
After reading this article, you should be able to:
Understand the pathophysiology of cystic fibrosis (CF); Explain which organs are affected by CFTR dysfunction; Identify the classes of drugs used to manage CFTR dysfunction and understand any considerations for efficacy or adverse effects; Understand how health in CF is monitored . Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Last updated 3 July 2024 11:00
Peer reviewed article This article has been peer reviewed by relevant subject experts prior to acceptance for publication. The reviewers
declared no relevant affiliations or financial involvement with any organisation or entity with a financial
involvement with any organisation or entity with a financial interest in or in financial conflict with the subject
matter or materials discussed in this article. 
